Cristina Alonso‐Vega

Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial

Faustino Torrico, Joaquím Gascón, Lourdes Ortiz et al. · The Lancet Infectious Diseases · 2018 · 292 citations · Full text

Pharmacology, Gastroenterology, Placebo-controlled Trial +2

MATERNAL TRYPANOSOMA CRUZI INFECTION, PREGNANCY OUTCOME, MORBIDITY, AND MORTALITY OF CONGENITALLY INFECTED AND NON-INFECTED NEWBORNS IN BOLIVIA

Faustino Torrico, Cristina Alonso‐Vega, Eduardo Suárez et al. · American Journal of Tropical Medicine and Hygiene · 2004 · 267 citations

B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10.

Liliane Schandené, Cristina Alonso‐Vega, Fabienne Willems et al. · The Journal of Immunology · 1994 · 251 citations

Adaptive Immune System, Immunology, Immune Regulation +16

New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial

Faustino Torrico, Joaquím Gascón, Fabiana Barreira et al. · The Lancet Infectious Diseases · 2021 · 194 citations · Full text

COMPARISON OF POLYMERASE CHAIN REACTION METHODS FOR RELIABLE AND EASY DETECTION OF CONGENITAL TRYPANOSOMA CRUZI INFECTION

Myrna Virreira, Faustino Torrico, Carine Truyens et al. · American Journal of Tropical Medicine and Hygiene · 2003 · 179 citations